Related Experiment Video
Updated: Feb 7, 2026
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
New insights into cardiovascular disease in patients with Kawasaki disease
Jane C Burns1, Tomoyo Matsubara2
1Department of Pediatrics, University of California San Diego and Rady Children's Hospital, San Diego, California, USA.
Insights
Kawasaki disease, a condition affecting children, shows increasing case numbers globally. Further research is crucial for understanding its causes, improving treatments, and managing long-term cardiovascular effects.
Area of Science:
- Pediatric Rheumatology
- Infectious Diseases
- Cardiology
Background:
- Kawasaki disease poses diagnostic and management challenges for multiple medical specialists.
- Understanding disease pathogenesis, treatment, and long-term outcomes remains critical.
Purpose of the Study:
- To review progress in understanding Kawasaki disease pathogenesis.
- To discuss current treatment strategies and long-term patient outcomes.
- To highlight unmet needs in clinical trials and observational studies.
Main Methods:
- Review of epidemiologic studies.
- Analysis of clinical trial data (or lack thereof).
- Synthesis of emerging data on long-term consequences.
Main Results:
- Increasing Kawasaki disease case numbers observed globally, suggesting true incidence rise.
- Unmet need for adequately powered clinical trials on adjunctive therapies.
- Emerging evidence of long-term arterial wall and myocardial damage.
Conclusions:
- The etiology of Kawasaki disease remains unknown.
- A specific diagnostic test is lacking.
- Further longitudinal studies are essential to define long-term cardiovascular outcomes and guide future research.
Purpose Of Review:
Kawasaki disease presents many challenges to the diverse group of physicians who care for these patients including infectious disease specialists, rheumatologists, and cardiologists. Here we review some of the progress being made toward improved understanding of disease pathogenesis, treatment, and long-term outcomes.
Recent Findings:
Epidemiologic studies in different populations documented increasing numbers of cases in countries with high physician awareness of the disease. These data suggest true increases in patient numbers rather than increases because of increased case ascertainment. Adequately powered clinical trials for adjunctive therapies continue to be an unmet need. Long-term consequences of damage to the arterial wall and myocardium are beginning to emerge and systematic, longitudinal observational studies are needed to better define outcomes.
Summary:
The unknown cause, lack of a specific diagnostic test, and uncertain future for patients who develop permanent cardiovascular damage all require further study.
Related Concept Videos
01:27Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:25Immunodeficiency Diseases
There are three main causes of immunodeficiency...
01:24Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
01:22Alzheimer's Disease: Treatment
01:26Principles of Disease Surveillance